StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
47
This year
5
Publishing Date
2024 - 03 - 13
1
2024 - 03 - 07
1
2024 - 03 - 05
1
2024 - 03 - 04
1
2024 - 02 - 08
1
2023 - 12 - 13
1
2023 - 11 - 08
1
2023 - 11 - 03
1
2023 - 10 - 24
2
2023 - 08 - 02
1
2023 - 07 - 27
1
2023 - 05 - 24
1
2023 - 05 - 08
1
2023 - 05 - 02
1
2023 - 03 - 21
1
2023 - 03 - 08
1
2023 - 03 - 02
1
2023 - 02 - 22
1
2022 - 12 - 13
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 11 - 01
1
2022 - 10 - 18
1
2022 - 09 - 13
1
2022 - 08 - 18
1
2022 - 08 - 11
1
2022 - 08 - 05
1
2022 - 07 - 28
1
2022 - 07 - 15
2
2022 - 07 - 06
1
2022 - 06 - 15
1
2022 - 05 - 23
1
2022 - 04 - 25
1
2022 - 03 - 15
2
2022 - 03 - 10
1
2022 - 03 - 01
1
2022 - 02 - 17
1
2022 - 02 - 10
1
2022 - 02 - 08
1
2022 - 01 - 26
1
2021 - 12 - 15
1
2021 - 11 - 11
1
2021 - 11 - 08
1
2021 - 11 - 04
1
Sector
Health technology
3
N/a
1
Professional, scientific, and technical services
47
Tags
Agreement
1
Alliances
4
Als
9
Biocapital
11
Canada
1
China
1
Clearance
3
Conference
6
Disease
1
Distribution
9
Ema
2
Europe
2
Expected
1
Fda
3
Financial
11
International
1
Label
2
License
2
Liver
1
Million
1
N/a
24
Offering
3
Ongoing
2
Patent
1
People
1
Pharm-country
1
Pharmaceutical
4
Pharmaceuticals
24
Positive
2
Qrx003
12
Rare
1
Report
2
Research
1
Results
13
Russia
1
Set
7
Study
1
Submission
2
Syndros
5
Test
1
Treatment
1
Trial
6
Update
15
Year
1
Entities
Acumen pharmaceuticals inc
52
Acurx pharmaceuticals llc
54
Akoya biosciences inc
78
Alzamend neuro inc
44
Biomea fusion inc
89
Biorestorative therapies, inc.
55
Bioxytran, inc
41
Briacell therapeutics corp.
100
Century therapeutics inc
48
Clinuvel pharmaceuticals ltd
110
Compass therapeutics inc
35
Connect biopharma holdings ltd - adr
36
Cyclo therapeutics inc - class a
67
Day one biopharmaceuticals inc
48
Definitive healthcare corp.
44
Elevation oncology inc
41
Endonovo therapeutics, inc.
32
Entrada therapeutics inc
34
Finch therapeutics group inc
35
First advantage corp.
45
Gain therapeutics inc
69
Genedx holdings corp - class a
41
Hive blockchain technologies ltd.
35
Icoreconnect inc.
35
Immunoprecise antibodies ltd
84
Impel neuropharma inc.
38
Instil bio inc
31
Intertek group plc
157
Ispecimen inc
62
Legalzoom.com inc.
34
Lianbio - adr
47
Lonza group ag
95
Medicine man technologies, inc.
31
Miromatrix medical inc
47
Mister car wash inc
35
Molecular partners ag - adr
61
Monte rosa therapeutics inc
42
Morgan stanley
45
Omniq corp
110
Panbela therapeutics inc
99
Prometheus biosciences inc
35
Pyxis oncology inc
45
Quoin pharmaceuticals ltd - adr
47
Recursion pharmaceuticals inc - class a
53
Reneo pharmaceuticals inc
50
Sage group plc
74
Sap se
49
Seer inc - class a
48
Singular genomics systems inc
41
Sunshine biopharma, inc
33
Thermo fisher scientific inc
59
Transcode therapeutics inc
74
Tscan therapeutics inc
73
Unicycive therapeutics inc
41
Uphealth inc
52
Vectivbio holding ag
60
Vera therapeutics inc - class a
60
Verve therapeutics inc
40
Werewolf therapeutics inc
44
Xilio therapeutics inc
37
Symbols
ENDP
3
ENDPQ
1
QNRX
47
Exchanges
Nasdaq
47
Crawled Date
2024 - 03 - 13
1
2024 - 03 - 07
1
2024 - 03 - 05
1
2024 - 03 - 04
1
2024 - 02 - 08
1
2023 - 12 - 13
1
2023 - 11 - 08
1
2023 - 11 - 03
1
2023 - 10 - 24
2
2023 - 08 - 02
1
2023 - 07 - 27
1
2023 - 05 - 24
1
2023 - 05 - 08
1
2023 - 05 - 02
1
2023 - 03 - 21
1
2023 - 03 - 09
1
2023 - 03 - 02
1
2023 - 02 - 22
1
2022 - 12 - 13
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 11 - 01
1
2022 - 10 - 18
1
2022 - 09 - 13
1
2022 - 08 - 18
1
2022 - 08 - 11
1
2022 - 08 - 05
1
2022 - 07 - 28
1
2022 - 07 - 15
2
2022 - 07 - 06
1
2022 - 06 - 15
1
2022 - 05 - 23
1
2022 - 04 - 25
1
2022 - 03 - 15
2
2022 - 03 - 10
1
2022 - 03 - 01
1
2022 - 02 - 17
1
2022 - 02 - 10
1
2022 - 02 - 08
1
2022 - 01 - 26
1
2021 - 12 - 15
1
2021 - 11 - 11
1
2021 - 11 - 08
1
2021 - 11 - 04
1
Crawled Time
00:00
1
11:00
1
12:00
5
12:30
2
13:00
7
13:20
3
13:30
5
14:00
7
14:20
1
14:30
1
15:20
2
15:30
2
16:00
2
20:00
1
21:00
4
22:00
1
23:00
2
Source
www.biospace.com
23
www.globenewswire.com
23
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Professional, scientific, and technical services
entities :
Quoin pharmaceuticals ltd - adr
save search
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
Published:
2024-03-13
(Crawled : 20:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-43.1%
|
O:
-3.45%
H:
1.51%
C:
-10.71%
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
Published:
2024-03-07
(Crawled : 21:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-44.53%
|
O:
12.61%
H:
2.16%
C:
-11.94%
conference
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
Published:
2024-03-05
(Crawled : 13:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-77.24%
|
O:
-44.48%
H:
8.07%
C:
-6.83%
million
offering
pharmaceuticals
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
Published:
2024-03-04
(Crawled : 13:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-76.17%
|
O:
113.71%
H:
4.39%
C:
-51.01%
fda
clearance
ongoing
pharmaceuticals
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
Published:
2024-02-08
(Crawled : 13:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-80.24%
|
O:
0.3%
H:
1.79%
C:
0.0%
patent
international
pharmaceuticals
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
Published:
2023-12-13
(Crawled : 13:30)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-85.81%
|
O:
5.38%
H:
4.77%
C:
-6.33%
qrx003
fda
clearance
pharmaceuticals
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results
Published:
2023-11-08
(Crawled : 23:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-85.08%
|
O:
7.12%
H:
0.0%
C:
-14.36%
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET
Published:
2023-11-03
(Crawled : 12:30)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-84.65%
|
O:
-2.79%
H:
11.0%
C:
6.46%
conference
update
pharmaceuticals
financial
results
REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
Published:
2023-10-24
(Crawled : 13:30)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-85.65%
|
O:
1.09%
H:
9.17%
C:
6.88%
positive
pharmaceuticals
trial
Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
Published:
2023-10-24
(Crawled : 12:30)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-85.65%
|
O:
1.09%
H:
9.17%
C:
6.88%
positive
pharmaceuticals
trial
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results
Published:
2023-08-02
(Crawled : 21:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-90.61%
|
O:
1.71%
H:
8.11%
C:
4.48%
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ET
Published:
2023-07-27
(Crawled : 12:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-91.24%
|
O:
0.0%
H:
9.96%
C:
0.0%
conference
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial
Published:
2023-05-24
(Crawled : 12:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.04%
|
O:
-1.59%
H:
1.79%
C:
-2.17%
label
pharmaceuticals
trial
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results
Published:
2023-05-08
(Crawled : 21:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.19%
|
O:
-3.68%
H:
0.46%
C:
-10.96%
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET
Published:
2023-05-02
(Crawled : 12:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.05%
|
O:
1.03%
H:
4.08%
C:
-2.02%
conference
update
pharmaceuticals
financial
results
Quoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trial
Published:
2023-03-21
(Crawled : 13:20)
- biospace.com/
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.06%
|
O:
0.08%
H:
4.02%
C:
3.98%
label
pharmaceuticals
trial
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and Full Year 2022 Financial Results
Published:
2023-03-08
(Crawled : 00:00)
- biospace.com/
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.18%
|
O:
-3.57%
H:
7.41%
C:
6.48%
pharmaceuticals
year
financial
update
results
Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call to be held on Thursday March 9th at 8:30am ET
Published:
2023-03-02
(Crawled : 21:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.16%
|
O:
-3.14%
H:
10.0%
C:
4.08%
pharmaceuticals
conference
update
Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Published:
2023-02-22
(Crawled : 14:00)
- globenewswire.com
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.61%
|
O:
-41.6%
H:
7.74%
C:
-10.79%
offering
pharmaceuticals
Quoin Pharmaceuticals Announces Dosing of First Patient in Clinical Trial in Netherton Syndrome
Published:
2022-12-13
(Crawled : 14:00)
- biospace.com/
QNRX
|
$0.66
-7.03%
-6.8%
130K
|
Professional, Scientific, and T...
|
-99.69%
|
O:
8.67%
H:
0.61%
C:
-5.52%
pharmaceuticals
trial
← Previous
1
2
3
Next →
Gainers vs Losers
73%
27%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
PROK
|
$2.72
33.33%
24.58%
2.6M
|
MIGI
|
$1.57
31.93%
24.2%
660K
|
Information
Your saved searches
Save your searches and get alerts when important news are released.